This Cochrane Clinical Answer evaluates anti-vascular endothelial growth factors for treatment of people with choroidal neovascularization associated with pathological myopia.
Sorry, it appears that you don't have a current subscription to COCHRANE CLINICAL ANSWERS.
A subscription to THE COCHRANE LIBRARY is required.
Login via OpenAthens
Search for your institution's name below to login via Shibboleth.